FDA OKs First IL-15 Receptor Agonist for Early Bladder Cancer

(MedPage Today) -- The FDA approved nogapendekin alfa inbakicept (Anktiva) for bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC), the agency announced Monday. A first-in-class interleukin (IL)-15 receptor...
Source: MedPage Today Public Health - Category: American Health Source Type: news